Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida

作者：Belén Hervera, Teresa A. Chueng, Joy D. Scheidell, Katrina Ciraldo, Sabrina Soto Sugar, Marina Plesons, Hansel Tookes, David P. Serota, Raymond R. Balise, Nobuyo Nakamura, Shelby Meaders, David W. Forrest, Tyler S. Bartholomew · 发表于：Harm Reduction Journal · 年份：2025 · DOI：10.1186/s12954-025-01266-0 · 被引用次数：5 · 研究领域：HIV, Drug Use, Sexual Risk、Opioid Use Disorder Treatment、HIV/AIDS Research and Interventions

BACKGROUND: Women who inject drugs (WWID) face disproportionately higher risks of infectious diseases, reproductive health challenges, and gendered social and structural vulnerabilities compared to men. Despite these elevated risks, most harm reduction programs do not tailor their services to meet the needs of WWID. In Florida, where syringe service programs are relatively new and implemented at the county-level, access remains limited. These gaps are especially pronounced for WWID, who face additional barriers due to restrictive reproductive policies and limited access to gender-responsive care. This study examined gender-related risks among people who inject drugs (PWID) accessing a SSP in Miami, Florida to inform harm reduction service delivery and intervention needs. METHODS: This study analyzed enrollment data from the first legal SSP in Florida collected from its December 2016 inception through July 2022 (N = 1660). In bivariate analyses, we used chi-square tests to describe differences in sociodemographic, injection drug use (IDU) and sexual behaviors, and infectious disease prevalence between men and women. We used multivariable logistic regression models to estimate associations between gender and IDU behaviors, sexual behaviors, and HIV/HCV prevalence, adjusting for age, race/ethnicity, housing status, and enrollment year. RESULTS: Our sample included 1660 participants (26% women). Compared to men, WWID had significantly higher odds of sharing syringes (adjusted odd...